<DOC>
	<DOCNO>NCT00424411</DOCNO>
	<brief_summary>To determine , subject Type 2 Diabetes Mellitus : 1 . Whether glycemic control achieve least effectively insulin regimen involve pre-meal EXUBERA™ ( inhaled insulin ) plus single bedtime Ultralente injection conventional subcutaneous insulin regimen involve 2 mixed Regular/NPH insulin injection per day . 2 . The toleration safety EXUBERA™ ( inhaled insulin ) therapy effect 6 month , , measure pulmonary function .</brief_summary>
	<brief_title>Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 2 Diabetes Stable insulin regimen least 2 injection per day Any smoking within last 6 month . Smoking permitted time study . Subjects insulin pump 2 month prior screen . Subjects poorlycontrolled asthma , clinically significant chronic obstructive pulmonary disease , significant respiratory disease .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2007</verification_date>
</DOC>